Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of…
Vocodia Holdings (VHAI) to Transform Auto Dealership Experience with Groundbreaking AI…
Black Diamond Therapeutics Inc (NASDAQ:BDTX) Surges on Market Optimism
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Amarin Corporation Plc (NASDAQ:AMRN)
Tag: Amarin Corporation Plc (NASDAQ:AMRN)
Amarin (NASDAQ:AMRN)Established That VASCEPA® can Reduce Ischemic Events In Individuals That...
Kate Hudson
-
October 28, 2020
0
Amarin Corporation plc (NASDAQ:AMRN) Supported New Data from Clinical Research Evaluating...
Ward Sport
-
September 7, 2020
0
Amarin Corporation Plc (NASDAQ:AMRN) Reports A Growth Of 34% YoY In...
Matt Wade
-
August 24, 2020
0
Amarin Corporation plc (NASDAQ:AMRN) says it is Supporting Investigator-Initiated Trial Evaluating...
Ward Sport
-
August 19, 2020
0
Data from the REDUCE-IT® REVASC Analysis Presented by Amarin Corporation plc....
Gavins Felicity
-
August 14, 2020
0
1
2
3
Page 2 of 3
Recent Post
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
Kate Hudson
-
March 26, 2024
0
In a landmark development, the U.S. Food and Drug Administration recently endorsed a groundbreaking therapy by Merck, setting a new course for...
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
March 25, 2024
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of...
March 25, 2024
Vocodia Holdings (VHAI) to Transform Auto Dealership Experience with Groundbreaking AI...
March 25, 2024
Black Diamond Therapeutics Inc (NASDAQ:BDTX) Surges on Market Optimism
March 22, 2024